Overview
ENSURE HEALTHY LIVES AND PROMOTE WELL-BEING FOR ALL AT ALL AGES
---
3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births
3.2 By 2030, end preventable deaths of newborns and under-five children
GRI Indicators: former FP4 (Food Processing Sector Disclosure)
3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria, and neglected tropical diseases and combat hepatitis, water-borne diseases, and other communicable diseases
3.4 By 2030, reduce by one-third pre-mature mortality from non-communicable diseases (NCDs) through prevention and treatment, and promote mental health and wellbeing
3.5 Strengthen prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol
GRI Indicators: M4, M5
3.6 By 2020, halve global deaths and injuries from road traffic accidents
3.7 By 2030, ensure universal access to sexual and reproductive health care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programs
Poverty Footprint Indicators: PF-14.7 iii)
3.8 Achieve universal health coverage (UHC), including financial risk protection, access to quality essential health care services, and access to safe, effective, quality, and affordable essential medicines and vaccines for all
GRI Indicator: G4-EC8
Poverty Footprint Indicators: PF-13.7, PF-14.1, PF-14.4, PF-14.7 ii)
Access to Medicine Index Indicators: D.I.1, D.I.2, D.III.2
3.9 By 2030 substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water, and soil pollution and contamination
GRI Indicators: G4-LA6, G4-LA7, G4-EN15, G4-EN16, G4-EN17, G4-EN20, G4-EN21, G4-EN22, G4-EN23, G4-EN24, G4-EN25, AO4, AO5, AO6, CRE5, MM1, MM3, MM8, OG5, OG6, OG7, OG9, OG13
---
3.a. Strengthen implementation of the Framework Convention on Tobacco Control in all countries as appropriate
3.b. Support research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration which affirms the right of developing countries to use to the full the provisions in the TRIPS agreement regarding flexibilities to protect public health and, in particular, provide access to medicines for all
Access to Medicine Indicators: B.III.4, C.III.1, E.I.1, E.II.1, E.III.2
3.c. Increase substantially health financing and the recruitment, development and training and retention of the health workforce in developing countries, especially in LDCs and SIDS
Access to Medicine Indicators: G.I.3, G.III.3, G.III.4
3.d. Strengthen the capacity of all countries, particularly developing countries, for early warning, risk reduction, and management of national and global health risks